Longevity Startups

Foxo offers a precision longevity program combining systems-biology diagnostics, biomarker and ageing-clock testing, AI-driven personalization, lifestyle and therapeutic interventions, and healthspan coaching. It targets biological ageing at the cellular level to help individuals extend healthspan and maintain cognitive and physical performance.

1 investor

FutureYou Health develops natural dietary supplements—such as magnesium, NAD+, and turmeric formulations—focused on bioavailability and health areas like energy, healthy ageing, and gut health. Based in Cambridge, UK, the company develops products with input from a scientific advisory board and ties to University of Cambridge research institutions.

1 investor

Gamida Cell develops allogeneic cell therapy products using its proprietary nicotinamide (NAM) technology to enhance and expand cells for treating patients with hematologic and non-hematologic conditions. The company focuses on research, development, manufacturing, and commercialization of cell therapies for malignant and non-malignant hematological diseases.

1 investor

General Biotechnologies manufactures peptide therapeutics by genetically programming edible microbes to synthesise molecules, aiming to produce them at lower cost. It focuses on reviving clinically proven but discontinued off-patent peptides as low-cost oral drugs, including an oral GLP-1, and partners with pharma companies to bring shelved assets back as oral formulations.

1 investor

Gero is a biotech company applying AI, data science, and physics-based models of human health to discover drug targets and therapies for aging and age-related chronic diseases. It develops a therapeutic pipeline using longitudinal health data, statistical genetics, and multi-omics.

1 investor

Glyscend Therapeutics is a clinical-stage biopharmaceutical company developing oral, first-in-class therapies for type 2 diabetes and obesity. Its approach originated from research on how certain bariatric surgeries improve glucose and metabolic regulation and produce sustained weight loss.

1 investor

Goyaba is a well-being curator that creates, acquires, and nurtures lifestyle brands focused on longevity, supplements, and superfoods. The company builds a community-driven ecosystem around physical and mental well-being for consumers seeking products and lifestyles that support longer, healthier living.

1 investor

Gutcrine is a Danish biotech developing pharmabiotics derived from gut microbiome hormone synthesis, aimed at the prevention and treatment of cardio-metabolic disorders.

1 investor

Habitat Health operates PACE (Program of All-Inclusive Care for the Elderly) centers offering medical care, social services, home care, and transportation for adults age 55 and older. It serves seniors in Sacramento and South Los Angeles, California.

1 investor

Longevity Health Holdings develops products focused on longevity, healthy aging, and regenerative bio-aesthetics, including skincare and cosmetics lines. Its consumer brands aim to help people look and feel their best at any age.

1 investor

A longevity and anti-aging medical clinic offering personalized programs (e.g. Longevity 360, hormone balance, regenerative medicine, brain and heart health) built on advanced diagnostics such as bloodwork, DNA and epigenetic testing, DEXA, and imaging, paired with treatments including hormone replacement, peptide, IV, and cell therapies. It serves individuals seeking to extend healthspan and lifespan, with clinic locations in Miami's Design District (South Florida) and Prague, Czech Republic.

1 investor

Healz analyzes up to 100 advanced biomarkers across 8 specialized panels to identify biological causes of symptoms like fatigue, brain fog, weight changes, and low performance, providing clinical interpretation and a 30-day action plan. It serves both individuals and companies, offering an anonymized corporate dashboard for workforce health, with CE IVDR certification and a focus on the European market.

1 investor

Hemostemix is a clinical-stage regenerative medicine company developing ACP-01, an investigational autologous (patient-derived) stem cell therapy for vascular and ischemic conditions such as critical limb ischemia, peripheral arterial disease, ischemic cardiomyopathy, and heart failure. The company runs Phase I and Phase II clinical programs and is publicly traded (TSXV: HEM | OTCQB: HMTXF).

1 investor

Holaglow operates aesthetic medicine clinics offering aesthetic medicine, advanced aesthetics, cosmetic surgery, and longevity treatments applied by professionals. It runs its own clinics in 7 cities in Spain and provides personalized advice, financing options, and post-treatment care.

1 investor

Honor Technology develops technology platforms and operates brands that provide goods and services for aging adults, aiming to support independent living. The company works in the aging care and healthtech space.

1 investor

Humanaut Health operates preventive and longevity medicine clinics offering advanced diagnostics (300 to 1,000+ biomarkers, imaging, and functional testing) paired with provider-built, personalized health protocols delivered through annual memberships. It serves individuals seeking proactive health optimization, with clinic locations in Austin, TX and Palm Beach Gardens, FL, and offers therapies such as stem cell treatment, hormone optimization, and peptide protocols.</parameter> <parameter name="founders">[{"full_name": "Amy Killen", "title": "Chief Medical Officer and Co-Founder"}, {"full_name": "Harry Adelson", "title": "Chief of Regenerative Medicine and Co-Founder"}, {"full_name": "Ernesto Navarro", "title": "Chief Longevity Officer, Humanaut PLLC"}, {"full_name": "P. Jeffrey Smith", "title": "Group Medical Director, Humanaut PLLC"}]

1 investor

Humble+ makes dietary supplements focused on healthy aging, including marine collagen, creatine, protein blends, and formulas targeting sleep, energy, and cardiovascular/cognitive health. Products are sold direct to consumers and through more than 700 partner pharmacies and points of sale in France.

1 investor

Hummsa Biotech develops next-generation oral GLP-1 receptor agonist therapies targeting the root causes of obesity, diabetes, and related metabolic and chronic diseases. Its lead candidate, HB PKO02, is an oral small molecule designed to regenerate insulin-producing beta cells to restore function and enable prevention rather than symptom management.

1 investor

Immunique is a science-based biotech company developing cell therapies that restore balance in the immune system to treat disease and support long-term patient recovery. Its research focuses on immune cell function and is aimed at extending healthy lifespan through clinical- and data-driven treatment strategies.

1 investor

Immunocodex develops tolerogenic mRNA vaccines that reprogram immune cells and rebalance the immune system to treat autoimmune diseases. Its platform combines tolerance-inducing signals with disease-specific autoantigens to target conditions such as multiple sclerosis, type I diabetes, rheumatoid arthritis, and celiac disease.

1 investor

InnovAge operates as a Program of All-Inclusive Care for the Elderly (PACE), providing comprehensive healthcare services for seniors. It serves elderly patients in the United States.

1 investor

Instalab provides comprehensive health testing, physician consultations, and personalized health protocols designed for busy founders and entrepreneurs. The service combines biomarker analysis with lifestyle optimization to improve daily performance and support longevity while fitting into demanding startup schedules.

1 investor

Integrated Biosciences is a drug discovery company developing small-molecule therapeutics for age-related diseases by combining optogenetics, synthetic biology, chemistry, and AI on its integrated platform. It focuses on probing the systems biology of aging to identify new therapeutic opportunities.

1 investor

锦欣康养 is a subsidiary of Jinxin Medical Group that operates elderly care services combining medical treatment and senior living, including institutional care, home and community care, geriatric medicine, rehabilitation, and nursing. It runs care facilities and senior apartments across the Chengdu-Chongqing region, the Yangtze River Delta, and the Greater Bay Area in China.

1 investor